Ketamine and its derivative esketamine given during or right after elective cesarean deliveries may help lower postpartum depression symptoms during the first two weeks of recovery, according to a meta-analysis presented at the ANESTHESIOLOGY 2026 annual meeting. The research team reviewed six randomized controlled trials conducted between January 2015 and September 2025, tracking 1,832 women who underwent surgical births [1]. While operating room teams routinely use the drug for anesthesia and surgical pain control, researchers wanted to see whether it also altered maternal mood during early healing [2]. The analysis revealed a small-to-moderate drop in depressive symptom scores on postoperative screening questionnaires, offering a potential tool for mothers recovering from major surgery [1].
Surgical Delivery and Postpartum Depression Symptoms
Undergoing a Cesarean delivery carries an increased risk of postpartum depression symptoms, which often include persistent sadness, anxiety, irritability, a loss of interest in daily routines, and difficulty bonding with a baby [1]. For mothers recovering from major abdominal surgery, bodily surgical pain often combines with the emotional demands of early infant care [2]. This recovery window prompted researchers at FIU Herbert Wertheim College of Medicine in Miami to ask whether surgical medications could help [1].
Postpartum depression affects about one in five women following childbirth, creating personal and family strain during the vulnerable weeks after delivery [1]. Hospital teams have long sought practical ways to ease recovery during this period, particularly because surgical delivery already involves anesthesia specialists and intravenous medication lines [2]. Ketamine works by blocking NMDA receptors in the central nervous system, a mechanism that provides surgical pain relief while also producing fast-acting antidepressant effects in psychiatric clinics. PerEXP Teamworks previously reported on how ketamine affects brain signaling and causes body disconnection, explaining how the compound alters neural communication pathways [1]. That dual background as an operating room anesthetic and a fast-acting psychiatric tool made Ketamine a compelling candidate for obstetric surgical trials [2].
Trial Results Across Six Surgical Studies
Elective Cesarean procedures provide a controlled clinical setting for evaluating such medications. Patients receive close monitoring from anesthesia teams throughout delivery and during postoperative care in recovery units [1]. Individual studies rarely enroll enough surgical patients to provide definitive evidence on their own, especially when tracking mood fluctuations across different hospital settings. By pooling data from six separate trials spanning a decade, investigators obtained a more dependable assessment [2].
The new meta-analysis gathered evidence from six randomized controlled trials published from January 2015 through September 2025, tracking 1,832 women undergoing elective C-sections who received Ketamine, the derivative esketamine, or comparison care without either drug [1]. In reporting on the presentation, Medical Xpress and Developments Today reviewed how pooled surgical data clarified early outcomes [2]. Patients who received Ketamine or esketamine showed a reduction in depressive symptom scores, reaching a standardized mean difference of -0.36, which was statistically significant across the cohorts. Lead author Peter Hsin, a medical student at FIU Herbert Wertheim College of Medicine in Miami, explained the practical implication. “Ketamine is known for its rapid antidepressant effects in psychiatric settings, and our findings suggest it may offer benefits beyond anesthesia and pain relief for women having a C-section,” said Hsin [1].
How Researchers Measured Maternal Recovery
To evaluate changes in patient mood, the six trials relied on the Edinburgh Postnatal Depression Scale, a widely recognized screening survey designed to detect emotional distress following birth. In each trial, clinical teams administered the survey between postoperative day three and day 14 [1]. Tracking scores during this specific phase allowed researchers to see whether Ketamine influenced mood while the body was healing from operative stress [2].
While the Edinburgh Postnatal Depression Scale provides a standardized measure of depressive symptoms, a lower score on a screening questionnaire is not the same as preventing a clinical disease. Screening tools detect early symptoms such as sadness, tearfulness, or sleep trouble, but they do not provide a formal medical diagnosis of major depressive disorder. As Developments Today pointed out, symptom scores can fluctuate during surgical recovery without indicating a lasting psychiatric outcome [2]. Peter Hsin addressed that distinction when discussing what the evidence proves. “This is promising, but it is too early to say that ketamine prevents clinically diagnosed postpartum depression or that it should be used routinely,” said Hsin [1]. Obstetric teams require proof showing whether early symptom drops translate into sustained mental health protection over longer recovery periods [2].
Postpartum Depression Symptoms and Early Care Limits
Medical researchers caution that easing postpartum depression symptoms in the first two weeks does not mean hospitals should change standard delivery care today. The meta-analysis reviewed by Peter Hsin and Rose Berkun focused on women undergoing planned elective procedures, where surgical conditions remain calm and predictable [1]. Emergency Cesarean births, by contrast, involve urgent medical complications, high maternal stress, and bodily strain that may alter drug responses. Dosing timing also varied across the six trials [2].
Patient safety also requires careful study before anesthetic medications can be repurposed for routine maternal mood management. Ketamine can cause temporary side effects, including mild perceptual changes, grogginess, or brief confusion as patients emerge from anesthesia. For new mothers who need to nurse, hold, and care for their infants right after surgery, any lingering drug effects require close clinical monitoring [2]. Hsin pointed out that answering these safety and practical questions requires larger trials with extended evaluation. “While our findings suggest ketamine may modestly ease early depressive symptoms, larger studies with longer follow-up are needed to determine the best dose and timing, and whether ketamine can help prevent postpartum depression,” said Hsin [1]. Until such studies conclude, doctors view the meta-analysis as an encouraging signal rather than an immediate change in clinical practice [2].
Planned Research at the University at Buffalo
Within the University at Buffalo Department of Anesthesiology, researchers are organizing new clinical investigations with extended monitoring timelines in New York [1]. Instead of relying on older retrospective studies, a forward-looking trial allows researchers to set exact doses and track patients for months. This prospective structure helps doctors observe how long maternal mood benefits actually last during post-hospital recovery [2]. Controlled protocols also allow teams to measure safety directly [1].
Study co-author Dr. Rose Berkun, an associate professor of anesthesiology at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo in New York, is helping lead this next investigation. The planned trial will take place within the University at Buffalo Department of Anesthesiology, testing Ketamine during Cesarean delivery in a controlled prospective framework. “We plan to conduct a prospective, randomized study in the Department of Anesthesiology at the University at Buffalo to further evaluate the potential role of ketamine administered during cesarean delivery in reducing the incidence and severity of postpartum depression,” said study co-author Rose Berkun, M.D., FASA, associate professor of anesthesiology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, New York. By tracking both the frequency and severity of depressive signs over months, the Buffalo team aims to clarify which mothers benefit most from operating room care [1].
Clinical Care Beyond the Operating Room
Even if prospective trials confirm that Ketamine eases early mood difficulties, surgical interventions cannot replace comprehensive postpartum care. Maternal mental health depends on ongoing cooperation among obstetricians, primary care doctors, and community mental health teams throughout the first year of life. Hospital protocols offering temporary relief can only serve as one part of an integrated maternal support network. Surgical care addresses only the earliest days of recovery [2].
Routine screening is necessary for identifying mothers who develop postpartum depression symptoms weeks or months after hospital discharge. Because depressive disorders can emerge at any point during the postpartum year, standard questionnaires such as the Edinburgh Postnatal Depression Scale must continue at routine pediatric and obstetric checkups. Just as research into biological triggers behind severe morning sickness helped doctors recognize bodily risks in pregnancy, postpartum research points to the value of ongoing monitoring [2]. The meta-analysis presented by Peter Hsin and his colleagues shows that surgical delivery settings can offer fresh avenues for studying maternal mental health. By administering Ketamine or esketamine around the time of surgery, doctors observed modest short-term improvements during the most demanding days of recovery [1]. Yet both the study authors and independent medical commentators agree that stronger clinical evidence must precede any changes to standard surgical care [2].
- ONLINE NEWS Harley, S., & Zinin, A. (2026, October 17). Ketamine during or after C-sections may ease early postpartum depression symptoms, new study suggests. Medical Xpress. [Article Link]
- ONLINE NEWS DT Editorial Team. (2026, October 17). Ketamine May Ease Early Postpartum Symptoms After C-Sections. Developments Today. [Article Link]
APA 7: PerEXP Teamworks. (2026, October 17). Ketamine May Ease Postpartum Depression Symptoms After C-Sections.
